Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01229228 · ClinicalTrials.gov registry record · Phase 2
Study of Naproxen Capsules to Treat Dental Pain
A Phase 2 study, sponsored by Iroko Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 254
- Enrollment target
NCT01229228 is a Phase 2 study that has completed, run by Iroko Pharmaceuticals. The registered enrollment target is 254 participants.
The verdict
NCT01229228, a Phase 2 study, has completed, sponsored by Iroko Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 254 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether Naproxen Test Formulation Capsules are safe and effective for the treatment of dental pain.
Interventions
- DRUG Placebo
- DRUG Naproxen Test
- DRUG Naprosyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01229228
The ClinicalTrials.gov registry entry for NCT01229228 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iroko Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01229228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01229228 about?
NCT01229228 is a clinical study titled "Study of Naproxen Capsules to Treat Dental Pain". The purpose of the study is to determine whether Naproxen Test Formulation Capsules are safe and effective for the treatment of dental pain.
What is the current status of trial NCT01229228?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 254 participants. The study started on 2010-10. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01229228?
The interventions under investigation include: Placebo (DRUG), Naproxen Test (DRUG), Naprosyn (DRUG).
Who is sponsoring clinical trial NCT01229228?
This trial is sponsored by Iroko Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.